Furthermore, Engel et al. reported a significant molecular signature in which MSH6 mutation carriers are associated with low frequency of CTNNB1 mutations and high frequency of APC mutations, suggesting that in these patients the onset of MMR deficiency only occurs after adenoma formation. Here, CTNNB1 is linked to adenoma.